Paces Ferry Wealth Advisors’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$666K Sell
7,358
-12
-0.2% -$1K 0.25% 56
2026
Q1
$590K Hold
7,370
0.24% 55
2025
Q4
$628K Sell
7,370
-58
-0.8% -$4.76K 0.26% 55
2025
Q3
$578K Hold
7,428
0.24% 57
2025
Q2
$581K Hold
7,428
0.27% 55
2025
Q1
$538K Sell
7,428
-142
-2% -$10.2K 0.27% 57
2024
Q4
$560K Sell
7,570
-38
-0.5% -$2.66K 0.27% 53
2024
Q3
$502K Sell
7,608
-1,200
-14% -$87.2K 0.29% 57
2024
Q2
$814K Hold
8,808
0.49% 44
2024
Q1
$842K Sell
8,808
-300
-3% -$25.2K 0.54% 41
2023
Q4
$694K Hold
9,108
0.48% 47
2023
Q3
$631K Sell
9,108
-8
-0.1% -$643 0.5% 45
2023
Q2
$860K Hold
9,116
0.65% 40
2023
Q1
$754K Buy
9,116
+26
+0.3% +$2.04K 0.61% 43
2022
Q4
$678K Sell
9,090
-71
-0.8% -$5.47K 0.66% 36
2022
Q3
$757K Sell
9,161
-2,993
-25% -$288K 0.83% 32
2022
Q2
$1.16M Buy
12,154
+32
+0.3% +$3.31K 1.14% 26
2022
Q1
$1.43M Hold
12,122
1.13% 25
2021
Q4
$1.57M Hold
12,122
1.13% 25
2021
Q3
$1.37M Hold
12,122
1.1% 27
2021
Q2
$1.25M Sell
12,122
-2
-0% -$189 0.96% 30
2021
Q1
$1.01M Hold
12,124
0.88% 29
2020
Q4
$1.11M Buy
12,124
+4
+0% +$332 1.01% 29
2020
Q3
$967K Buy
+12,120
New +$946K 0.84% 29

Other funds holding EW

Paces Ferry Wealth Advisors's EW Position: Q2 2026 in Review

Paces Ferry Wealth Advisors reduced its Edwards Lifesciences (EW) stake by 0.16% in Q2 2026, selling an estimated $1K and leaving 7,358 shares worth $666K. The position accounts for 0.25% of the portfolio, ranked #56.

Paces Ferry Wealth Advisors first reported a position in EW in Q3 2020 and has held it in 24 quarters since. The position peaked at $1.57M in Q4 2021. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Paces Ferry Wealth Advisors held 7,358 shares of Edwards Lifesciences worth $666K as of Q2 2026.
  • Paces Ferry Wealth Advisors sold 12 Edwards Lifesciences shares in Q2 2026, an estimated $1K.
  • Edwards Lifesciences made up 0.25% of Paces Ferry Wealth Advisors's portfolio in Q2 2026, its #56 holding.
  • Paces Ferry Wealth Advisors first reported a position in Edwards Lifesciences in Q3 2020 and has held it in 24 quarters since.
  • Paces Ferry Wealth Advisors's Edwards Lifesciences position peaked at $1.57M in Q4 2021.
  • 1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Paces Ferry Wealth Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.